Macrophage endocytosis in resolving lung inflammation
巨噬细胞内吞作用解决肺部炎症
基本信息
- 批准号:8454234
- 负责人:
- 金额:$ 63.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdult Respiratory Distress SyndromeAnti-Inflammatory AgentsAnti-inflammatoryApoptoticAutoimmunityAutomobile DrivingCellsChronicChronic Obstructive Airway DiseaseClinicalDefectDevelopmentDiseaseEndocytosisEnvironmentExcisionFibrosisHomeostasisIndiumInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseIngestionInjuryInterleukin-4Interstitial Lung DiseasesLeukocytesLungLung InflammationLung diseasesMaintenanceMediatingOrganPPAR gammaParticulatePathogenesisPathway interactionsPhasePhenotypePhosphatidylserinesPneumoniaProcessProductionPropertyReactionRecruitment ActivityResolutionRoleSignal PathwaySignal TransductionSiteSourceStagingStimulusStructureTestingTherapeuticTissuesVariantWound Healinghuman diseaseimmunogenicimprovedin vivomacrophagemonocyteneutrophilnovelparasitismprogramsrepairedresponsetraffickinguptake
项目摘要
DESCRIPTION (provided by applicant): Inflammation is an essential effector process for responses to parasitism, infection and tissue injury. On the other hand, it also contributes to the
pathogenesis of most human diseases. This paradox results in part from the fact that inflammation itself can, and often does; itself induce injury to the tissues in the process of resolving the infection or healing the wound. Optimally, therefore, an acute inflammatory response completes its protective (and pro-immunogenic) functions and then rapidly resolves, allowing the tissue to return to normal structure and function. A key element in this resolution is removal of the inflammatory cells themselves as well as the cell and tissue debris that is produced as an inevitable accompaniment to the process. This clearance function is primarily carried out by uptake of debris and cells into macrophages that accumulate at the site as part of the inflammatory process. Studies of macrophages in inflammation have tended in the past to focus on their contribution to recognizing the injurious stimulus in the first place, and in controlling the inflammation by virtue of their sequential production of pro- and then anti- inflammatory mediators. More recently, however, their participation in the resolution phase is becoming better understood, and, we hypothesize, results from a change in macrophage function that we identify as a change in "programing state". In particular, the reparative macrophages are hypothesized to gain a substantial capacity for macropinocytosis, the ingestion process suggested to remove both dying inflammatory cells and the particulate, and even soluble, debris that accompanies inflammation. Questions that are to be addressed in the proposal include: 1) demonstrating that macrophages with specifically high capability for macropinocytosis develop in the resolving inflamed lung and are effective scavengers of both debris and dying inflammatory cells, 2) distinguishing between incoming monocytes or previously macropinocytosis-poor macrophages as the source for such scavenger cells, 3) exploring the mechanism driving the macrophage programing by testing a proposed phosphatidylserine/IL- 4/PPARgamma signaling pathway (i.e. suggesting that it develops as a response to the presence of the activated and dying inflammatory cells themselves), 4) demonstrating that the pro-macropinocytic programing state and thus, clearance of inflammatory debris, can be enhanced in vivo by stimulating these pathways to improve the resolution.
描述(由申请人提供):炎症是对寄生虫、感染和组织损伤做出反应的基本效应过程。另一方面,它也有助于
大多数人类疾病的发病机制。这种悖论的部分原因是,炎症本身可以,而且通常确实会;在解决感染或愈合伤口的过程中,它本身会对组织造成伤害。因此,最好的情况是,急性炎症反应完成其保护性(和促免疫原性)功能,然后迅速消退,使组织恢复正常结构和功能。这项决议的一个关键要素是清除炎症细胞本身以及不可避免地伴随这一过程而产生的细胞和组织碎片。这种清除功能主要是通过将碎片和细胞摄取到巨噬细胞中来实现的,巨噬细胞在炎症过程中聚集在部位。巨噬细胞在炎症中的研究过去往往集中在它们在识别最初的伤害性刺激方面的贡献,以及通过它们顺序地产生促炎和抗炎介质来控制炎症。然而,最近,人们对它们参与分解阶段的理解变得更好了,我们推测,这是由于巨噬细胞功能的变化,我们认为这是“编程状态”的变化。特别是,修复性巨噬细胞被假设为获得大量的巨噬细胞吞噬能力,摄取过程表明既可以清除垂死的炎症细胞,也可以清除伴随炎症而来的颗粒,甚至是可溶的碎片。建议中要解决的问题包括:1)证明具有特别高巨噬细胞吞噬能力的巨噬细胞在消退炎症的肺中发展,并且是碎片和死亡炎症细胞的有效清除者;2)区分进入的单核细胞或先前缺乏巨噬细胞吞噬能力的巨噬细胞作为这种清道夫细胞的来源;3)通过测试所提出的磷脂酰丝氨酸/IL-4/PPAR-γ信号通路来探索驱动巨噬细胞编程的机制(即,表明它是对激活的和正在死亡的炎症细胞本身的存在的反应);4)证明支持巨噬细胞的编程状态,从而清除炎症碎片,通过刺激这些途径来提高分辨率,可以在体内增强。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER M HENSON其他文献
PETER M HENSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER M HENSON', 18)}}的其他基金
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
间质和气腔巨噬细胞在解决肺部炎症中的作用
- 批准号:
10655327 - 财政年份:2020
- 资助金额:
$ 63.71万 - 项目类别:
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
间质和气腔巨噬细胞在解决肺部炎症中的作用
- 批准号:
10407521 - 财政年份:2020
- 资助金额:
$ 63.71万 - 项目类别:
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
间质和气腔巨噬细胞在解决肺部炎症中的作用
- 批准号:
10171614 - 财政年份:2020
- 资助金额:
$ 63.71万 - 项目类别:
Macrophage endocytosis in resolving lung inflammation
巨噬细胞内吞作用解决肺部炎症
- 批准号:
8708954 - 财政年份:2013
- 资助金额:
$ 63.71万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.71万 - 项目类别:
Research Grant














{{item.name}}会员




